Drug Trial Radar · NCT02586155
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
Last checked: Nov 19, 2026Latest source record: Aug 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,425
Actual
Start
Nov 2015
Primary completion
Nov 30, 2020
Study completion Jun 21, 2021
Sponsor
- Lead sponsor
- Resverlogix CorpIndustry
- Sponsor type
- Industry
- Collaborators
- PPD Development, LP; ICON plc; Medidata Solutions
- First posted
- Oct 26, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether bromodomain extraterminal domain (BET) inhibition treatment with RVX000222 in high-risk type 2 diabetes mellitus patients with coronary artery disease increases the time to major adverse cardiovascular events.
Conditions
- Diabetes Mellitus, Type 2
- Coronary Artery Disease
Interventions
ApabetaloneDrug
100 mg capsule
PlaceboDrug
Capsule manufactured to mimic RVX000222 100 mg capsule
AtorvastatinDrug
High-Intensity Statin
RosuvastatinDrug
High-Intensity Statin
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of First Occurrence of Adjudication-confirmed Narrowly Defined MACETime frame: 120 weeks
Locations
214 sites in 15 countries. Site status is shown where the registry gives one.
Instituto de Investigaciones Clinicas Bahia Blanca
Bahía Blanca, Argentina
Bioclinica Buenos Aires
Buenos Aires, Argentina
Centro Privado de Enfermedades Cardiovasculares
Buenos Aires, Argentina
Consultorios Asociados Endocronología E Investigación Clínica Aplicada
Buenos Aires, Argentina
Instituto Cardiovascular de Buenos Aires
Buenos Aires, Argentina
Sanatorio Guemes
Buenos Aires, Argentina
CEMAIC
Córdoba, Argentina
Centro Médico Colón
Córdoba, Argentina
Centro Médico Luquez
Córdoba, Argentina
Clínica Privada Del Prado Sociedad de Responsabilidad Limitada
Córdoba, Argentina
Fundación Clínica Colombo
Córdoba, Argentina
Hospital Cordoba
Córdoba, Argentina
Hospital San Roque
Córdoba, Argentina
Instituto Del Corazón
Córdoba, Argentina
Instituto Modelo de Cardiologia
Córdoba, Argentina
Instituto Médico DAMIC
Córdoba, Argentina
Ipac Caraffa
Córdoba, Argentina
Sanatorio Allende
Córdoba, Argentina
Clinica Coronel Suarez
Coronel Suárez, Argentina
Instituto de Cardiologia de Corrientes Juana Francisca Cabral
Corrientes, Argentina
Centro Médico Libertad
Haedo, Argentina
CIMEL
Lanus, Argentina
Instituto de Investigaciones Clínicas Mar Del Plata
Mar del Plata, Argentina
Hospital Central
Mendoza, Argentina
DIM Clinica Privada
Ramos Mejía, Argentina
Instituto de Hematologia Y Medicina Clinica
Rosario, Argentina
Sanatorio Britanico de Rosario
Rosario, Argentina
Prevencion Cardio Vascular
Salta, Argentina
Grupo Medico Alem
San Isidro, Argentina
Bioclinica Tucumán
San Miguel de Tucumán, Argentina
Centro Modelo de Cardiologia
San Miguel de Tucumán, Argentina
Investigaciones Clinicas Tucuman
San Miguel de Tucumán, Argentina
Centro de Investigaciones Clínicas Del Litoral SRL
Santa Fe, Argentina
Sanatorio San Francisco
Santiago del Estero, Argentina
Clínica FUSAVIM Privada
Villa María, Argentina
Instituto de Investigaciones Clínicas Zárate
Zárate, Argentina
Flinders Medical Centre
Bedford Park, Australia
ZNA Middelheim
Antwerp, Belgium
Imelda VZW
Bonheiden, Belgium
AZ Turnhout
Turnhout, Belgium
Showing 40 of 214 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.